Related Experiment Video
Updated: Oct 12, 2025

RhoC GTPase Activation Assay
Published on: August 22, 2010
The Large GTPase, GBP-2, Regulates Rho Family GTPases to Inhibit Migration and Invadosome Formation in Breast Cancer
Geoffrey O Nyabuto1, John P Wilson1, Samantha A Heilman1
1Department of Biological Sciences, University of Toledo, Toledo, OH 43606, USA.
Abstract:
Breast cancer is the most common cancer in women. Despite advances in early detection and treatment, it is predicted that over 43,000 women will die of breast cancer in 2021. To lower this number, more information about the molecular players in breast cancer are needed. Guanylate-Binding Protein-2 has been correlated with better prognosis in breast cancer. In this study, we asked if the expression of GBP-2 in breast cancer merely provided a biomarker for improved prognosis or whether it actually contributed to improving outcome. To answer this, the 4T1 model of murine breast cancer was used. 4T1 cells themselves are highly aggressive and highly metastatic, while 67NR cells, isolated from the same tumor, do not leave the primary site. The expression of GBP-2 was examined in the two cell lines and found to be inversely correlated with aggressiveness/metastasis. Proliferation, migration, and invadosome formation were analyzed after altering the expression levels of GBP-2. Our experiments show that GBP-2 does not alter the proliferation of these cells but inhibits migration and invadosome formation downstream of regulation of Rho GTPases. Together these data demonstrate that GBP-2 is responsible for cell autonomous activities that make breast cancer cells less aggressive.
Insights
Guanylate-Binding Protein-2 (GBP-2) expression in breast cancer cells inhibits metastasis and invadosome formation. This suggests GBP-2 actively improves patient outcomes, rather than just indicating a better prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Breast cancer remains a leading cause of death in women, necessitating further understanding of its molecular mechanisms.
- Guanylate-Binding Protein-2 (GBP-2) has been associated with improved breast cancer prognosis.
- The precise role of GBP-2 in breast cancer progression requires elucidation.
Purpose of the Study:
- To determine if Guanylate-Binding Protein-2 (GBP-2) expression is a biomarker for better breast cancer prognosis or if it actively contributes to improved outcomes.
- To investigate the functional role of GBP-2 in breast cancer cell aggressiveness.
Main Methods:
- Utilized the 4T1 murine breast cancer model, comparing highly aggressive 4T1 cells with less aggressive 67NR cells.
- Analyzed GBP-2 expression levels in both cell lines.
- Manipulated GBP-2 expression to assess its impact on cell proliferation, migration, and invadosome formation.
Main Results:
- GBP-2 expression was inversely correlated with aggressiveness and metastasis in the studied cell lines.
- GBP-2 did not affect cancer cell proliferation.
- GBP-2 significantly inhibited cancer cell migration and invadosome formation, downstream of Rho GTPase regulation.
Conclusions:
- GBP-2 actively suppresses breast cancer cell aggressiveness through cell-autonomous mechanisms.
- GBP-2's inhibition of migration and invadosome formation suggests a direct role in reducing metastatic potential.
- These findings highlight GBP-2 as a potential therapeutic target for reducing breast cancer invasiveness.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cell Polarization by Rho Proteins
Cancer Cell Migration through Invadopodia
GTPases and their Regulation
Large G-proteins,...
The Ras Gene
Ras is a...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...

